CV Weekly Digest | 2026-07-18

1. Aortic Valve Hemodynamic Physiology: New Insights to Improve Patient Selection

Summary: This perspective asks whether conventional resting hemodynamic measures adequately identify patients with aortic stenosis who will benefit from valve replacement. It integrates classical valve-area physiology, flow-gradient relationships, exercise hemodynamics, and outcome observations after TAVR or SAVR. The authors emphasize that roughly one-third of treated patients obtain no meaningful symptomatic or functional improvement and argue for physiology-informed, patient-specific selection.

Why it is must-read: 直面主动脉瓣狭窄干预获益判断的核心难题，为外科与心脏团队优化患者选择提供生理学框架。

Connection to my topic: 与血流动力学建模研究共同强调，应同时评估瓣膜梗阻、流量和心室反应。

Publication info: JACC: Cardiovascular Interventions; 2026-07-13; 10.1016/j.jcin.2026.04.050; Link: https://www.jacc.org/doi/10.1016/j.jcin.2026.04.050

2. Integrated lumped parameter modeling of cardiac–vascular interaction with valve dynamics and ventricular pressure–volume

Summary: This study asks how ventricular elastance, vascular properties, and aortic-valve stenosis interact to determine pressure, flow, and stroke volume. Investigators built a time-varying lumped-parameter model, benchmarked its waveforms against a reference model, and performed sensitivity analyses of compliance, minimum elastance, and stenosis severity. Stenosis severity dominated the peak transvalvular gradient but had less influence on stroke volume, supporting reduced-order modeling for ventricular-valvular assessment.

Why it is must-read: 以可解释的降阶模型解析瓣膜狭窄与心室—血管耦合，为患者特异性模拟提供方法学基础。

Connection to my topic: 为首篇提出的生理学个体化评估提供定量工具，并解释相似跨瓣压差下不同心室反应。

Publication info: Frontiers in Bioengineering and Biotechnology; 2026-07-13; 10.3389/fbioe.2026.1841734; Link: https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1841734/full

3. Consecutive Emergency Carotid Artery Stenting and Transcatheter Aortic Valve Replacement in a Patient With Cardiogenic Shock: A Case Report

Summary: This report examines rescue treatment for severe symptomatic aortic stenosis complicated by cardiogenic shock and critical carotid stenosis. The team performed emergency carotid artery stenting followed consecutively by TAVR to manage both cerebral and hemodynamic risk. Completion of both procedures demonstrates the technical feasibility of a carefully sequenced endovascular strategy in an exceptionally unstable patient.

Why it is must-read: 展示心源性休克合并严重颈动脉病变时，主动脉瓣急诊干预的程序排序与跨学科决策。

Connection to my topic: 将前两篇的患者选择与血流动力学讨论延伸至极端不稳定患者的实际心脏团队管理。

Publication info: Catheterization and Cardiovascular Interventions; 2026-07-10; PMID: 42430181; Link: https://pubmed.ncbi.nlm.nih.gov/42430181/

4. Dragon's blood and its active components ameliorate pressure overload-induced heart failure via remodeling of cardiac lymphatics

Summary: This study asks whether Dragon's blood and its active constituents improve pressure-overload heart failure by acting on cardiac lymphatics. The authors used experimental pressure-overload models and evaluated cardiac remodeling together with lymphatic structural and functional responses. Treatment ameliorated heart failure and remodeled the cardiac lymphatic network, identifying lymphatic repair as a candidate mechanism of benefit.

Why it is must-read: 把心脏淋巴重塑引入压力负荷性心衰机制，为理解长期瓣膜梗阻后的心肌反应提供新视角。

Connection to my topic: 补充主动脉瓣狭窄血流动力学之外的下游组织重塑维度，聚焦炎症、水肿与纤维化相关机制。

Publication info: Journal of Ethnopharmacology; 2026-07-15; PMID: 41936836; Link: https://pubmed.ncbi.nlm.nih.gov/41936836/

5. Urolithin A activates mitophagy via the AMPK-mTOR axis and modulates the gut-ceramide axis to ameliorate cardiac remodeling in HFpEF

Summary: This study tested whether the microbiome-derived mitophagy activator urolithin A can reverse mechanistic abnormalities in HFpEF. Researchers used a high-fat-diet plus L-NAME mouse model, cellular experiments, multi-omics, and single-nucleus transcriptomics in human induced-pluripotent-stem-cell-derived cardiomyocytes. Urolithin A improved diastolic dysfunction, hypertrophy, fibrosis, mitochondrial function, and mitophagic flux through AMPK-mTOR-ULK1 signaling while reducing ceramide-associated lipotoxicity.

Why it is must-read: 通过动物、细胞、多组学与单核转录组整合，系统连接线粒体质量控制、脂毒性和心肌纤维化。

Connection to my topic: 与压力负荷研究共同拓展瓣膜病下游心肌重塑的机制图谱，突出纤维化与代谢稳态。

Publication info: Experimental & Molecular Medicine; 2026-07-10; PMID: 42432192; Link: https://pubmed.ncbi.nlm.nih.gov/42432192/

AI 见解

本周证据形成了从瓣膜梗阻生理、心室—血管定量建模到临床干预选择及下游心肌重塑的连续框架。最值得关注的共识是：跨瓣压差不能独立代表患者的整体病理负荷或干预获益，流量、心室顺应性、全身血管特性及不可逆心肌改变均需纳入判断。两项基础研究进一步提示，压力负荷后的淋巴网络、线粒体自噬、脂毒性与纤维化可能构成值得验证的心肌失代偿机制；但其与钙化性主动脉瓣病的直接联系仍需瓣膜组织和疾病特异性模型加以检验。